PriceTargets.com logo

Oscar Health - OSCR Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $14.86
  • Forecasted Upside: -13.48%
  • Number of Analysts: 11
  • Breakdown:
  • 5 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$17.17 As of 12/4/2025 04:59 PM ET
▲ +0.072 (0.42%)

This chart shows the closing price for OSCR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oscar Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OSCR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OSCR

Analyst Price Target is $14.86
▼ -13.48% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Oscar Health in the last 3 months. The average price target is $14.86, with a high forecast of $25.00 and a low forecast of $11.00. The average price target represents a -13.48% upside from the last price of $17.17.

This chart shows the closing price for OSCR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 11 contributing investment analysts is to reduce stock in Oscar Health. This rating has held steady since October 2025, when it changed from a Strong Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 5 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 6 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 5 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 5 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2025Piper SandlerUpgradeNeutral ➝ Overweight$13.00 ➝ $25.00
11/13/2025Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$14.00 ➝ $11.00
11/10/2025BarclaysBoost TargetUnderweight ➝ Underweight$11.00 ➝ $13.00
11/7/2025UBS GroupBoost TargetSell ➝ Sell$11.00 ➝ $12.00
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$17.00
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$17.00
10/13/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
10/8/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
10/7/2025Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$10.00 ➝ $14.00
9/27/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
8/14/2025Piper SandlerLower TargetNeutral ➝ Neutral$14.00 ➝ $13.00
7/25/2025Baird R WDowngradeStrong-Buy ➝ Hold
7/25/2025Robert W. BairdReiterated RatingOutperform ➝ Neutral$28.00 ➝ $14.00
7/23/2025BarclaysLower TargetUnderweight ➝ Underweight$17.00 ➝ $11.00
7/15/2025UBS GroupReiterated RatingNeutral ➝ Sell$15.00 ➝ $11.00
7/14/2025Piper SandlerDowngradeOverweight ➝ Neutral$14.00
7/11/2025Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $10.00
7/2/2025BarclaysInitiated CoverageUnderweight$17.00
6/24/2025Raymond James FinancialDowngradeOutperform ➝ Market Perform
6/9/2025Piper SandlerLower TargetOverweight ➝ Overweight$25.00 ➝ $18.00
3/13/2025Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$20.00 ➝ $16.00
12/10/2024Jefferies Financial GroupInitiated CoverageUnderperform$12.00
11/6/2024Bank of AmericaDowngradeNeutral ➝ Underperform$21.00 ➝ $13.50
10/7/2024UBS GroupInitiated CoverageNeutral$23.00
9/10/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$28.00 ➝ $28.00
8/8/2024Piper SandlerBoost TargetOverweight ➝ Overweight$25.00 ➝ $28.00
7/10/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00
6/26/2024Piper SandlerInitiated CoverageOverweight$25.00
6/12/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$24.00 ➝ $27.00
5/30/2024Baird R WUpgradeStrong-Buy
5/30/2024Robert W. BairdInitiated CoverageOutperform$28.00
5/30/2024Bank of AmericaReiterated RatingBuy ➝ Neutral$25.00 ➝ $21.00
5/20/2024Bank of AmericaBoost TargetBuy ➝ Buy$22.00 ➝ $25.00
5/9/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$20.00 ➝ $24.00
5/9/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$16.00 ➝ $21.00
3/22/2024Raymond James FinancialInitiated CoverageOutperform$20.00
2/15/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$12.00 ➝ $20.00
2/9/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$8.00 ➝ $16.00
11/2/2023Bank of AmericaUpgradeNeutral ➝ Buy$8.00 ➝ $9.00
8/30/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$5.00 ➝ $7.50
8/10/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$5.50 ➝ $7.50
8/9/2023Credit Suisse GroupBoost TargetOutperform ➝ Outperform$7.00 ➝ $8.50
7/14/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$5.00
6/6/2023Bank of AmericaUpgradeUnderperform ➝ Neutral$5.40 ➝ $8.75
3/29/2023Bank of AmericaBoost TargetUnderperform$3.25 ➝ $3.90
2/14/2023The Goldman Sachs GroupBoost TargetNeutral$3.50 ➝ $5.00
2/14/2023CowenBoost TargetMarket Perform$3.00 ➝ $6.00
2/10/2023Credit Suisse GroupLower TargetOutperform$7.00 ➝ $6.00
11/16/2022CowenLower Target$3.00
11/15/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$4.00
11/14/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$9.00 ➝ $5.00
9/1/2022Morgan StanleyLower TargetOverweight$12.00 ➝ $9.00
6/15/2022Bank of AmericaDowngradeNeutral ➝ Underperform$6.00 ➝ $4.50
6/9/2022Morgan StanleyLower TargetOverweight$18.00 ➝ $12.00
5/26/2022Bank of AmericaDowngradeBuy ➝ Neutral$12.00 ➝ $6.00
3/28/2022Morgan StanleyLower TargetOverweight$20.00 ➝ $18.00
2/14/2022Morgan StanleyBoost TargetOverweight$19.00 ➝ $20.00
1/7/2022Credit Suisse GroupLower TargetOutperform ➝ Outperform$21.00 ➝ $10.00
1/6/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$25.00 ➝ $9.00
12/17/2021Morgan StanleyLower TargetOverweight$22.00 ➝ $19.00
12/14/2021The Goldman Sachs GroupInitiated CoverageSell$6.50
11/12/2021Morgan StanleyLower TargetOverweight$26.00 ➝ $22.00
11/11/2021Wells Fargo & CompanyLower TargetOverweight$30.00 ➝ $25.00
11/11/2021Credit Suisse GroupLower TargetOutperform$26.00 ➝ $21.00
9/20/2021Credit Suisse GroupLower TargetOutperform$34.00 ➝ $26.00
9/9/2021CowenInitiated CoverageMarket Perform$15.00
8/31/2021Morgan StanleyLower TargetOverweight$44.00 ➝ $26.00
8/13/2021Wells Fargo & CompanyLower TargetOverweight$37.00 ➝ $30.00
3/29/2021Wells Fargo & CompanyInitiated CoverageOverweight$37.00
3/29/2021Bank of AmericaInitiated CoverageBuy$39.00
3/29/2021Morgan StanleyInitiated CoverageOverweight$44.00
3/29/2021CowenInitiated CoverageMarket Perform$29.00
3/29/2021The Goldman Sachs GroupInitiated CoverageBuy$44.00
3/29/2021Credit Suisse GroupInitiated CoverageOutperform$34.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 22 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 39 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 19 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
7/7/2025
  • 21 very positive mentions
  • 34 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
8/6/2025
  • 30 very positive mentions
  • 30 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 33 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 17 very positive mentions
  • 31 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/4/2025
  • 39 very positive mentions
  • 34 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 39 very positive mentions
  • 34 positive mentions
  • 9 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Oscar Health logo
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Read More

Today's Range

Now: $17.17
Low: $16.72
High: $17.67

50 Day Range

MA: $18.06
Low: $13.03
High: $22.44

52 Week Range

Now: $17.17
Low: $11.20
High: $23.80

Volume

8,032,559 shs

Average Volume

17,295,228 shs

Market Capitalization

$4.55 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Oscar Health?

The following Wall Street analysts have issued research reports on Oscar Health in the last year: Baird R W, Barclays PLC, Jefferies Financial Group Inc., Piper Sandler, Raymond James Financial, Inc., Robert W. Baird, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for OSCR.

What is the current price target for Oscar Health?

0 Wall Street analysts have set twelve-month price targets for Oscar Health in the last year. Their average twelve-month price target is $14.86, suggesting a possible downside of 13.5%. Piper Sandler has the highest price target set, predicting OSCR will reach $25.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $11.00 for Oscar Health in the next year.
View the latest price targets for OSCR.

What is the current consensus analyst rating for Oscar Health?

Oscar Health currently has 5 sell ratings, 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for OSCR.

What other companies compete with Oscar Health?

Other companies that are similar to Oscar Health include Brookfield Wealth Solutions, Aegon, Corebridge Financial, Ryan Specialty and Everest Group. Learn More about companies similar to Oscar Health.

How do I contact Oscar Health's investor relations team?

Oscar Health's physical mailing address is 75 Varick Street 5th Floor, New York NY, 10013. The company's listed phone number is 646-403-3677 and its investor relations email address is [email protected]. The official website for Oscar Health is www.hioscar.com. Learn More about contacing Oscar Health investor relations.